Menu
  • Join
  • Login
  • Contact
 

Search abstracts


Cardioselective beta blocker use in patients with chronic kidney disease: a National Population-Based Study

  • At: 2017 FIP Congress in Stockholm (Sweden)
  • Type: Presentation
  • By: WU, Ping-Hsun (Kaohsiung Medical University Hospital, Division of Nephrology, Departement of Internal Medicine, Kaohsiung, China Taiwan)
  • Co-author(s): Ping-Hsun Wu: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
    Yi-Ting Lin: Department of Family Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
    Ming-Yen Lin: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
    Hui-Min Hsieh: Department of Public Health, College of Health Sciences, Kaohsiung Medical University, Kaohsiung, Taiwan, Province of China
    Feng-Shiuan Jian: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
    Shang-Jhy Hwang: Division of Nephrology, Departement of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Province of China
    Yi-Huang Kang: Department of Information Management, National Sun Yat-sen University, Kaohsiung, Taiwan, Province of China
  • Abstract:

    Backgrounds

    β-blockers use is associated with improved cardiovascular outcomes in patients with cardiovascular disease. However, limited data focus on patients with chronic kidney disease (CKD). Besides, previous studies focused on the survival outcome and used a non-active comparison, prevalent-user design.

    Aims

    We investigated the effect of

    ..

  • The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses